Selskabet OBA-Pharma ApSActive
Key figures
Key ratios
2025/26Balance sheet structure
Dividends
from the annual reportProposed dividend for the financial year 974.000 kr. (100% of the profit for the year).
Proposed dividend from the annual report's profit allocation (normally paid the following year). If there is no proposal, the dividend paid according to the statement of changes in equity is shown.
Financial statements2025–2026
| 2024/25 | 2025/26 | |
|---|---|---|
| Balance sheet — assets | ||
| Cash and cash equivalents | 1.758.647 | 2.275.435 |
| Total current assets | 7.550.433 | 6.455.772 |
| Total non-current assets | — | — |
| Total assets | 7.550.433 | 6.455.772 |
| Balance sheet — liabilities and equity | ||
| Current liabilities | 5.948.399 | 5.079.619 |
| Non-current liabilities | 0 | 275.294 |
| Total liabilities | 5.948.399 | 5.354.913 |
| Share capital | 125.000 | 125.000 |
| Retained earnings of previous periods | 1.034 | 1.859 |
| Profit for the year | 1.475.783 | 974.825 |
| Total equity | 1.602.034 | 1.100.859 |
| Income statement | ||
| Gross profit | 1.987.697 | 1.434.475 |
| Operating profit | — | — |
| Profit before income tax | 1.885.049 | 1.270.119 |
| Profit for the reporting year | 1.475.783 | 974.825 |
| Labour costs | — | — |
| Depreciation of non-current assets | — | — |
| Other indicators | ||
| Employees | 0 | 0 |
| Dividends | 1.476.000 | 974.000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
About the company
Annual report 2026Selskabets hovedaktivitet har i lighed med tidligere år bestået i grossistvirksomhed inden for læge- middelbranchen.
Udvikling i regnskabsåret Selskabets resultat og økonomiske udvikling blev lavere end forventede ved regnskabsårets begyn- delse og anses for mindre tilfredsstillende. Selskabet forventer et positivt resultat for det kommende regnskabsår.
Excerpt from the management's review in the latest annual report.